HRT Financial’s PMV Pharmaceuticals PMVP Stock Holding History

HRT Financial’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67K	Buy	+50,510	New	+$64.8K	﹤0.01%	3712
2025 Q3	–	Sell	-22,437	Closed	-$23K	–	3482
2025 Q2	$23K	Buy	+22,437	New	+$22K	﹤0.01%	2382
2024 Q3	–	Sell	-12,014	Closed	-$19K	–	2975
2024 Q2	$19K	Buy	+12,014	New	+$21.7K	﹤0.01%	1940
2023 Q3	–	Sell	-48,323	Closed	-$302K	–	2939
2023 Q2	$302K	Sell	48,323 -244,329	-83%	-$1.28M	﹤0.01%	1628
2023 Q1	$1.4M	Buy	292,652 +137,450	+89%	+$967K	0.02%	786
2022 Q4	$1.35M	Buy	155,202 +89,206	+135%	+$951K	0.02%	770
2022 Q3	$785K	Buy	+65,996	New	+$953K	0.01%	1088

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

HRT Financial's PMVP Position: Q2 2026 in Review

HRT Financial opened a new position in PMV Pharmaceuticals (PMVP) in Q2 2026: 50,510 shares worth $67K. The stake represents ﹤0.01% of the portfolio and ranks #3712 among its holdings. This is a return to the name: HRT Financial previously reported a position in PMVP as recently as Q2 2025.

HRT Financial first reported a position in PMVP in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

HRT Financial held 50,510 shares of PMV Pharmaceuticals worth $67K as of Q2 2026.
PMV Pharmaceuticals was a new HRT Financial position in Q2 2026.
PMV Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3712 holding.
HRT Financial first reported a position in PMV Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
HRT Financial's PMV Pharmaceuticals position peaked at $1.4M in Q1 2023.
64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.